nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP1A1—Dacarbazine—sarcoma	0.156	0.187	CbGbCtD
Propranolol—CYP1A2—Dacarbazine—sarcoma	0.0696	0.0835	CbGbCtD
Propranolol—CYP3A7—Vincristine—sarcoma	0.0665	0.0799	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0665	0.0799	CbGbCtD
Propranolol—CYP3A4—Thiotepa—sarcoma	0.0658	0.0789	CbGbCtD
Propranolol—ABCB1—Dactinomycin—sarcoma	0.0527	0.0633	CbGbCtD
Propranolol—CYP3A5—Vincristine—sarcoma	0.0499	0.0599	CbGbCtD
Propranolol—ABCB1—Mitoxantrone—sarcoma	0.0472	0.0567	CbGbCtD
Propranolol—CYP3A5—Etoposide—sarcoma	0.0457	0.0549	CbGbCtD
Propranolol—CYP1A2—Etoposide—sarcoma	0.034	0.0409	CbGbCtD
Propranolol—ABCB1—Vincristine—sarcoma	0.0325	0.039	CbGbCtD
Propranolol—ABCB1—Etoposide—sarcoma	0.0298	0.0357	CbGbCtD
Propranolol—CYP3A4—Mitoxantrone—sarcoma	0.0283	0.0339	CbGbCtD
Propranolol—ABCB1—Doxorubicin—sarcoma	0.0203	0.0244	CbGbCtD
Propranolol—CYP3A4—Vincristine—sarcoma	0.0195	0.0234	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—sarcoma	0.0191	0.023	CbGbCtD
Propranolol—CYP3A4—Etoposide—sarcoma	0.0178	0.0214	CbGbCtD
Propranolol—CYP3A4—Doxorubicin—sarcoma	0.0122	0.0146	CbGbCtD
Propranolol—HTR1B—dura mater—sarcoma	0.00688	0.45	CbGeAlD
Propranolol—ADRB3—connective tissue—sarcoma	0.001	0.0654	CbGeAlD
Propranolol—Erythema—Dactinomycin—sarcoma	0.000782	0.00516	CcSEcCtD
Propranolol—Pharyngitis—Mitoxantrone—sarcoma	0.000776	0.00512	CcSEcCtD
Propranolol—Neutropenia—Etoposide—sarcoma	0.00076	0.00502	CcSEcCtD
Propranolol—Atrioventricular block—Epirubicin—sarcoma	0.000748	0.00494	CcSEcCtD
Propranolol—Cardiac disorder—Vincristine—sarcoma	0.000745	0.00492	CcSEcCtD
Propranolol—Infestation NOS—Etoposide—sarcoma	0.000724	0.00478	CcSEcCtD
Propranolol—Infestation—Etoposide—sarcoma	0.000724	0.00478	CcSEcCtD
Propranolol—Agitation—Thiotepa—sarcoma	0.000724	0.00478	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000718	0.00474	CcSEcCtD
Propranolol—Abnormal dreams—Epirubicin—sarcoma	0.000717	0.00474	CcSEcCtD
Propranolol—Hyperkalaemia—Epirubicin—sarcoma	0.000713	0.00471	CcSEcCtD
Propranolol—Alopecia—Vincristine—sarcoma	0.000709	0.00468	CcSEcCtD
Propranolol—Mental disorder—Vincristine—sarcoma	0.000703	0.00464	CcSEcCtD
Propranolol—Atrioventricular block—Doxorubicin—sarcoma	0.000692	0.00457	CcSEcCtD
Propranolol—Alopecia—Mitoxantrone—sarcoma	0.000691	0.00456	CcSEcCtD
Propranolol—Cough—Thiotepa—sarcoma	0.000688	0.00454	CcSEcCtD
Propranolol—Convulsion—Thiotepa—sarcoma	0.000683	0.00451	CcSEcCtD
Propranolol—Erythema—Mitoxantrone—sarcoma	0.000681	0.00449	CcSEcCtD
Propranolol—Agranulocytosis—Etoposide—sarcoma	0.000676	0.00446	CcSEcCtD
Propranolol—Dry eye—Epirubicin—sarcoma	0.00067	0.00443	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000666	0.0044	CcSEcCtD
Propranolol—Abnormal dreams—Doxorubicin—sarcoma	0.000664	0.00438	CcSEcCtD
Propranolol—Hyperkalaemia—Doxorubicin—sarcoma	0.00066	0.00436	CcSEcCtD
Propranolol—Agitation—Vincristine—sarcoma	0.000642	0.00424	CcSEcCtD
Propranolol—Infection—Thiotepa—sarcoma	0.000639	0.00422	CcSEcCtD
Propranolol—Infection—Dactinomycin—sarcoma	0.000634	0.00419	CcSEcCtD
Propranolol—Nervous system disorder—Thiotepa—sarcoma	0.000631	0.00416	CcSEcCtD
Propranolol—Vertigo—Vincristine—sarcoma	0.000628	0.00414	CcSEcCtD
Propranolol—Skin disorder—Thiotepa—sarcoma	0.000625	0.00412	CcSEcCtD
Propranolol—Dry eye—Doxorubicin—sarcoma	0.00062	0.0041	CcSEcCtD
Propranolol—Erythema multiforme—Etoposide—sarcoma	0.000615	0.00406	CcSEcCtD
Propranolol—Convulsion—Vincristine—sarcoma	0.000605	0.004	CcSEcCtD
Propranolol—Cardiac disorder—Etoposide—sarcoma	0.000604	0.00398	CcSEcCtD
Propranolol—Cough—Mitoxantrone—sarcoma	0.000594	0.00392	CcSEcCtD
Propranolol—Convulsion—Mitoxantrone—sarcoma	0.00059	0.00389	CcSEcCtD
Propranolol—Vascular purpura—Epirubicin—sarcoma	0.000589	0.00389	CcSEcCtD
Propranolol—Cardiac failure congestive—Epirubicin—sarcoma	0.000581	0.00384	CcSEcCtD
Propranolol—Paraesthesia—Thiotepa—sarcoma	0.000578	0.00381	CcSEcCtD
Propranolol—Alopecia—Etoposide—sarcoma	0.000575	0.00379	CcSEcCtD
Propranolol—Somnolence—Thiotepa—sarcoma	0.000572	0.00377	CcSEcCtD
Propranolol—Anaphylactic shock—Vincristine—sarcoma	0.00057	0.00377	CcSEcCtD
Propranolol—Infection—Vincristine—sarcoma	0.000567	0.00374	CcSEcCtD
Propranolol—Dyspepsia—Thiotepa—sarcoma	0.000566	0.00374	CcSEcCtD
Propranolol—Nervous system disorder—Vincristine—sarcoma	0.000559	0.00369	CcSEcCtD
Propranolol—Decreased appetite—Thiotepa—sarcoma	0.000559	0.00369	CcSEcCtD
Propranolol—Dermatitis exfoliative—Epirubicin—sarcoma	0.000558	0.00369	CcSEcCtD
Propranolol—Anaphylactic shock—Mitoxantrone—sarcoma	0.000555	0.00367	CcSEcCtD
Propranolol—Gastrointestinal disorder—Thiotepa—sarcoma	0.000555	0.00367	CcSEcCtD
Propranolol—Decreased appetite—Dactinomycin—sarcoma	0.000555	0.00366	CcSEcCtD
Propranolol—Fatigue—Thiotepa—sarcoma	0.000555	0.00366	CcSEcCtD
Propranolol—Infection—Mitoxantrone—sarcoma	0.000552	0.00364	CcSEcCtD
Propranolol—Fatigue—Dactinomycin—sarcoma	0.00055	0.00363	CcSEcCtD
Propranolol—Constipation—Thiotepa—sarcoma	0.00055	0.00363	CcSEcCtD
Propranolol—Pain—Thiotepa—sarcoma	0.00055	0.00363	CcSEcCtD
Propranolol—Purpura—Epirubicin—sarcoma	0.000547	0.00361	CcSEcCtD
Propranolol—Pain—Dactinomycin—sarcoma	0.000546	0.0036	CcSEcCtD
Propranolol—Vascular purpura—Doxorubicin—sarcoma	0.000545	0.0036	CcSEcCtD
Propranolol—Anaphylactoid reaction—Epirubicin—sarcoma	0.000544	0.00359	CcSEcCtD
Propranolol—Hypoglycaemia—Epirubicin—sarcoma	0.00054	0.00356	CcSEcCtD
Propranolol—Skin disorder—Mitoxantrone—sarcoma	0.00054	0.00356	CcSEcCtD
Propranolol—Lethargy—Epirubicin—sarcoma	0.000538	0.00355	CcSEcCtD
Propranolol—Cardiac failure congestive—Doxorubicin—sarcoma	0.000538	0.00355	CcSEcCtD
Propranolol—Gastrointestinal pain—Thiotepa—sarcoma	0.000526	0.00347	CcSEcCtD
Propranolol—Gastrointestinal pain—Dactinomycin—sarcoma	0.000522	0.00345	CcSEcCtD
Propranolol—Affect lability—Epirubicin—sarcoma	0.000519	0.00342	CcSEcCtD
Propranolol—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000517	0.00341	CcSEcCtD
Propranolol—Insomnia—Vincristine—sarcoma	0.000516	0.00341	CcSEcCtD
Propranolol—Paraesthesia—Vincristine—sarcoma	0.000512	0.00338	CcSEcCtD
Propranolol—Urticaria—Thiotepa—sarcoma	0.000511	0.00337	CcSEcCtD
Propranolol—Vertigo—Etoposide—sarcoma	0.000509	0.00336	CcSEcCtD
Propranolol—Abdominal pain—Thiotepa—sarcoma	0.000508	0.00336	CcSEcCtD
Propranolol—Body temperature increased—Thiotepa—sarcoma	0.000508	0.00336	CcSEcCtD
Propranolol—Purpura—Doxorubicin—sarcoma	0.000506	0.00334	CcSEcCtD
Propranolol—Abdominal pain—Dactinomycin—sarcoma	0.000505	0.00333	CcSEcCtD
Propranolol—Body temperature increased—Dactinomycin—sarcoma	0.000505	0.00333	CcSEcCtD
Propranolol—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000504	0.00333	CcSEcCtD
Propranolol—Cardiac arrest—Epirubicin—sarcoma	0.000501	0.00331	CcSEcCtD
Propranolol—Hypoglycaemia—Doxorubicin—sarcoma	0.0005	0.0033	CcSEcCtD
Propranolol—Mood swings—Epirubicin—sarcoma	0.000499	0.0033	CcSEcCtD
Propranolol—Paraesthesia—Mitoxantrone—sarcoma	0.000499	0.00329	CcSEcCtD
Propranolol—Lethargy—Doxorubicin—sarcoma	0.000498	0.00328	CcSEcCtD
Propranolol—Decreased appetite—Vincristine—sarcoma	0.000496	0.00327	CcSEcCtD
Propranolol—Dyspnoea—Mitoxantrone—sarcoma	0.000495	0.00327	CcSEcCtD
Propranolol—Cough—Etoposide—sarcoma	0.000494	0.00326	CcSEcCtD
Propranolol—Somnolence—Mitoxantrone—sarcoma	0.000494	0.00326	CcSEcCtD
Propranolol—Gastrointestinal disorder—Vincristine—sarcoma	0.000492	0.00325	CcSEcCtD
Propranolol—Fatigue—Vincristine—sarcoma	0.000492	0.00325	CcSEcCtD
Propranolol—Convulsion—Etoposide—sarcoma	0.00049	0.00324	CcSEcCtD
Propranolol—Dyspepsia—Mitoxantrone—sarcoma	0.000489	0.00323	CcSEcCtD
Propranolol—Pain—Vincristine—sarcoma	0.000488	0.00322	CcSEcCtD
Propranolol—Constipation—Vincristine—sarcoma	0.000488	0.00322	CcSEcCtD
Propranolol—Decreased appetite—Mitoxantrone—sarcoma	0.000483	0.00319	CcSEcCtD
Propranolol—ORM1—hematopoietic system—sarcoma	0.000482	0.0315	CbGeAlD
Propranolol—Affect lability—Doxorubicin—sarcoma	0.00048	0.00317	CcSEcCtD
Propranolol—Fatigue—Mitoxantrone—sarcoma	0.000479	0.00316	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000479	0.00316	CcSEcCtD
Propranolol—Pain—Mitoxantrone—sarcoma	0.000475	0.00314	CcSEcCtD
Propranolol—Constipation—Mitoxantrone—sarcoma	0.000475	0.00314	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000474	0.00313	CcSEcCtD
Propranolol—Hypersensitivity—Thiotepa—sarcoma	0.000474	0.00313	CcSEcCtD
Propranolol—Hypersensitivity—Dactinomycin—sarcoma	0.00047	0.0031	CcSEcCtD
Propranolol—Gastrointestinal pain—Vincristine—sarcoma	0.000466	0.00308	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—sarcoma	0.000464	0.00306	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—sarcoma	0.000462	0.00305	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—sarcoma	0.000462	0.00305	CcSEcCtD
Propranolol—Asthenia—Thiotepa—sarcoma	0.000461	0.00305	CcSEcCtD
Propranolol—Infection—Etoposide—sarcoma	0.000459	0.00303	CcSEcCtD
Propranolol—Asthenia—Dactinomycin—sarcoma	0.000458	0.00302	CcSEcCtD
Propranolol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000454	0.003	CcSEcCtD
Propranolol—Abdominal pain—Vincristine—sarcoma	0.000451	0.00298	CcSEcCtD
Propranolol—Body temperature increased—Vincristine—sarcoma	0.000451	0.00298	CcSEcCtD
Propranolol—Skin disorder—Etoposide—sarcoma	0.000449	0.00296	CcSEcCtD
Propranolol—Urticaria—Mitoxantrone—sarcoma	0.000441	0.00291	CcSEcCtD
Propranolol—Diarrhoea—Thiotepa—sarcoma	0.00044	0.00291	CcSEcCtD
Propranolol—Body temperature increased—Mitoxantrone—sarcoma	0.000439	0.0029	CcSEcCtD
Propranolol—Abdominal pain—Mitoxantrone—sarcoma	0.000439	0.0029	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000439	0.0029	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—sarcoma	0.000438	0.00289	CcSEcCtD
Propranolol—Diarrhoea—Dactinomycin—sarcoma	0.000437	0.00288	CcSEcCtD
Propranolol—Neutropenia—Epirubicin—sarcoma	0.000426	0.00281	CcSEcCtD
Propranolol—Dizziness—Thiotepa—sarcoma	0.000425	0.00281	CcSEcCtD
Propranolol—Hypersensitivity—Vincristine—sarcoma	0.00042	0.00277	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—sarcoma	0.000415	0.00274	CcSEcCtD
Propranolol—Dyspnoea—Etoposide—sarcoma	0.000412	0.00272	CcSEcCtD
Propranolol—Somnolence—Etoposide—sarcoma	0.000411	0.00271	CcSEcCtD
Propranolol—ADRB1—connective tissue—sarcoma	0.000409	0.0267	CbGeAlD
Propranolol—Hypersensitivity—Mitoxantrone—sarcoma	0.000409	0.0027	CcSEcCtD
Propranolol—Asthenia—Vincristine—sarcoma	0.000409	0.0027	CcSEcCtD
Propranolol—Vomiting—Thiotepa—sarcoma	0.000409	0.0027	CcSEcCtD
Propranolol—Infestation—Epirubicin—sarcoma	0.000406	0.00268	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—sarcoma	0.000406	0.00268	CcSEcCtD
Propranolol—Vomiting—Dactinomycin—sarcoma	0.000406	0.00268	CcSEcCtD
Propranolol—Rash—Thiotepa—sarcoma	0.000406	0.00268	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—sarcoma	0.000405	0.00268	CcSEcCtD
Propranolol—Dermatitis—Thiotepa—sarcoma	0.000405	0.00267	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000403	0.00266	CcSEcCtD
Propranolol—Rash—Dactinomycin—sarcoma	0.000402	0.00266	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—sarcoma	0.000402	0.00265	CcSEcCtD
Propranolol—Gastrointestinal disorder—Etoposide—sarcoma	0.000399	0.00263	CcSEcCtD
Propranolol—Asthenia—Mitoxantrone—sarcoma	0.000399	0.00263	CcSEcCtD
Propranolol—Fatigue—Etoposide—sarcoma	0.000398	0.00263	CcSEcCtD
Propranolol—Pain—Etoposide—sarcoma	0.000395	0.00261	CcSEcCtD
Propranolol—Constipation—Etoposide—sarcoma	0.000395	0.00261	CcSEcCtD
Propranolol—CYP3A7—liver—sarcoma	0.000395	0.0258	CbGeAlD
Propranolol—Neutropenia—Doxorubicin—sarcoma	0.000394	0.0026	CcSEcCtD
Propranolol—Diarrhoea—Vincristine—sarcoma	0.00039	0.00258	CcSEcCtD
Propranolol—Nausea—Thiotepa—sarcoma	0.000382	0.00252	CcSEcCtD
Propranolol—Diarrhoea—Mitoxantrone—sarcoma	0.00038	0.00251	CcSEcCtD
Propranolol—Nausea—Dactinomycin—sarcoma	0.000379	0.0025	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—sarcoma	0.000379	0.0025	CcSEcCtD
Propranolol—Gastrointestinal pain—Etoposide—sarcoma	0.000378	0.00249	CcSEcCtD
Propranolol—Dizziness—Vincristine—sarcoma	0.000377	0.00249	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—sarcoma	0.000376	0.00248	CcSEcCtD
Propranolol—Infestation—Doxorubicin—sarcoma	0.000376	0.00248	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000372	0.00246	CcSEcCtD
Propranolol—Bradycardia—Epirubicin—sarcoma	0.000371	0.00245	CcSEcCtD
Propranolol—Urticaria—Etoposide—sarcoma	0.000367	0.00242	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—sarcoma	0.000365	0.00241	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—sarcoma	0.000365	0.00241	CcSEcCtD
Propranolol—HTR1A—hematopoietic system—sarcoma	0.000365	0.0238	CbGeAlD
Propranolol—Vomiting—Vincristine—sarcoma	0.000363	0.00239	CcSEcCtD
Propranolol—Pharyngitis—Epirubicin—sarcoma	0.000362	0.00239	CcSEcCtD
Propranolol—Rash—Vincristine—sarcoma	0.00036	0.00237	CcSEcCtD
Propranolol—Dermatitis—Vincristine—sarcoma	0.000359	0.00237	CcSEcCtD
Propranolol—Vomiting—Mitoxantrone—sarcoma	0.000353	0.00233	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—sarcoma	0.000351	0.00232	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—sarcoma	0.000351	0.00231	CcSEcCtD
Propranolol—Rash—Mitoxantrone—sarcoma	0.00035	0.00231	CcSEcCtD
Propranolol—Dermatitis—Mitoxantrone—sarcoma	0.00035	0.00231	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—sarcoma	0.000345	0.00228	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—sarcoma	0.000343	0.00227	CcSEcCtD
Propranolol—Hypersensitivity—Etoposide—sarcoma	0.00034	0.00225	CcSEcCtD
Propranolol—CYP2C19—hematopoietic system—sarcoma	0.00034	0.0222	CbGeAlD
Propranolol—Nausea—Vincristine—sarcoma	0.000339	0.00224	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—sarcoma	0.000338	0.00223	CcSEcCtD
Propranolol—CYP3A7-CYP3A51P—liver—sarcoma	0.000336	0.0219	CbGeAlD
Propranolol—Pharyngitis—Doxorubicin—sarcoma	0.000335	0.00221	CcSEcCtD
Propranolol—Asthenia—Etoposide—sarcoma	0.000331	0.00219	CcSEcCtD
Propranolol—Nausea—Mitoxantrone—sarcoma	0.00033	0.00218	CcSEcCtD
Propranolol—Visual impairment—Doxorubicin—sarcoma	0.000325	0.00215	CcSEcCtD
Propranolol—ADRB1—cardiac atrium—sarcoma	0.000323	0.0211	CbGeAlD
Propranolol—Alopecia—Epirubicin—sarcoma	0.000322	0.00213	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—sarcoma	0.000319	0.00211	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—sarcoma	0.000319	0.00211	CcSEcCtD
Propranolol—Erythema—Epirubicin—sarcoma	0.000317	0.00209	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—sarcoma	0.000316	0.00209	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—sarcoma	0.000313	0.00207	CcSEcCtD
Propranolol—ORM1—bone marrow—sarcoma	0.000309	0.0202	CbGeAlD
Propranolol—Dizziness—Etoposide—sarcoma	0.000306	0.00202	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—sarcoma	0.000298	0.00197	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—sarcoma	0.000295	0.00195	CcSEcCtD
Propranolol—Vomiting—Etoposide—sarcoma	0.000294	0.00194	CcSEcCtD
Propranolol—Erythema—Doxorubicin—sarcoma	0.000294	0.00194	CcSEcCtD
Propranolol—Agitation—Epirubicin—sarcoma	0.000292	0.00193	CcSEcCtD
Propranolol—Rash—Etoposide—sarcoma	0.000291	0.00192	CcSEcCtD
Propranolol—Dermatitis—Etoposide—sarcoma	0.000291	0.00192	CcSEcCtD
Propranolol—Vertigo—Epirubicin—sarcoma	0.000285	0.00188	CcSEcCtD
Propranolol—CYP1A2—hematopoietic system—sarcoma	0.000278	0.0182	CbGeAlD
Propranolol—Cough—Epirubicin—sarcoma	0.000277	0.00183	CcSEcCtD
Propranolol—Convulsion—Epirubicin—sarcoma	0.000275	0.00182	CcSEcCtD
Propranolol—Nausea—Etoposide—sarcoma	0.000274	0.00181	CcSEcCtD
Propranolol—CYP1A1—hematopoietic system—sarcoma	0.000274	0.0179	CbGeAlD
Propranolol—Agitation—Doxorubicin—sarcoma	0.00027	0.00178	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000268	0.00177	CcSEcCtD
Propranolol—CYP3A5—hematopoietic system—sarcoma	0.000268	0.0175	CbGeAlD
Propranolol—Vertigo—Doxorubicin—sarcoma	0.000264	0.00174	CcSEcCtD
Propranolol—Anaphylactic shock—Epirubicin—sarcoma	0.000259	0.00171	CcSEcCtD
Propranolol—Infection—Epirubicin—sarcoma	0.000257	0.0017	CcSEcCtD
Propranolol—Cough—Doxorubicin—sarcoma	0.000256	0.00169	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—sarcoma	0.000254	0.00168	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—sarcoma	0.000254	0.00168	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—sarcoma	0.000252	0.00166	CcSEcCtD
Propranolol—ORM1—liver—sarcoma	0.00025	0.0163	CbGeAlD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000248	0.00164	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—sarcoma	0.00024	0.00158	CcSEcCtD
Propranolol—CYP1A1—skin of body—sarcoma	0.000238	0.0156	CbGeAlD
Propranolol—Infection—Doxorubicin—sarcoma	0.000238	0.00157	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—sarcoma	0.000235	0.00155	CcSEcCtD
Propranolol—Insomnia—Epirubicin—sarcoma	0.000234	0.00155	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—sarcoma	0.000233	0.00154	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—sarcoma	0.000233	0.00154	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—sarcoma	0.000231	0.00152	CcSEcCtD
Propranolol—Somnolence—Epirubicin—sarcoma	0.00023	0.00152	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—sarcoma	0.000228	0.0015	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—sarcoma	0.000225	0.00149	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000224	0.00148	CcSEcCtD
Propranolol—Fatigue—Epirubicin—sarcoma	0.000223	0.00147	CcSEcCtD
Propranolol—Pain—Epirubicin—sarcoma	0.000221	0.00146	CcSEcCtD
Propranolol—Constipation—Epirubicin—sarcoma	0.000221	0.00146	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—sarcoma	0.000217	0.00143	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—sarcoma	0.000215	0.00142	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—sarcoma	0.000214	0.00141	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—sarcoma	0.000213	0.00141	CcSEcCtD
Propranolol—Gastrointestinal pain—Epirubicin—sarcoma	0.000212	0.0014	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—sarcoma	0.000211	0.00139	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—sarcoma	0.000208	0.00138	CcSEcCtD
Propranolol—CYP1A1—cardiac atrium—sarcoma	0.000208	0.0136	CbGeAlD
Propranolol—CYP1A1—uterus—sarcoma	0.000207	0.0135	CbGeAlD
Propranolol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000207	0.00137	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—sarcoma	0.000207	0.00136	CcSEcCtD
Propranolol—Urticaria—Epirubicin—sarcoma	0.000206	0.00136	CcSEcCtD
Propranolol—Pain—Doxorubicin—sarcoma	0.000205	0.00135	CcSEcCtD
Propranolol—Constipation—Doxorubicin—sarcoma	0.000205	0.00135	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—sarcoma	0.000205	0.00135	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—sarcoma	0.000205	0.00135	CcSEcCtD
Propranolol—CYP3A4—hematopoietic system—sarcoma	0.000201	0.0131	CbGeAlD
Propranolol—CYP2D6—hematopoietic system—sarcoma	0.000198	0.0129	CbGeAlD
Propranolol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000196	0.00129	CcSEcCtD
Propranolol—ORM1—lymph node—sarcoma	0.000191	0.0125	CbGeAlD
Propranolol—Hypersensitivity—Epirubicin—sarcoma	0.000191	0.00126	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—sarcoma	0.00019	0.00126	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—sarcoma	0.000189	0.00125	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—sarcoma	0.000189	0.00125	CcSEcCtD
Propranolol—Asthenia—Epirubicin—sarcoma	0.000186	0.00123	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—sarcoma	0.000177	0.00117	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—sarcoma	0.000177	0.00117	CcSEcCtD
Propranolol—CYP2C19—liver—sarcoma	0.000176	0.0115	CbGeAlD
Propranolol—Asthenia—Doxorubicin—sarcoma	0.000172	0.00113	CcSEcCtD
Propranolol—Dizziness—Epirubicin—sarcoma	0.000171	0.00113	CcSEcCtD
Propranolol—ABCB1—myometrium—sarcoma	0.000166	0.0108	CbGeAlD
Propranolol—Vomiting—Epirubicin—sarcoma	0.000165	0.00109	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—sarcoma	0.000164	0.00108	CcSEcCtD
Propranolol—Rash—Epirubicin—sarcoma	0.000163	0.00108	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—sarcoma	0.000163	0.00108	CcSEcCtD
Propranolol—ABCB1—embryo—sarcoma	0.00016	0.0104	CbGeAlD
Propranolol—Dizziness—Doxorubicin—sarcoma	0.000158	0.00105	CcSEcCtD
Propranolol—Nausea—Epirubicin—sarcoma	0.000154	0.00102	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—sarcoma	0.000152	0.00101	CcSEcCtD
Propranolol—Rash—Doxorubicin—sarcoma	0.000151	0.000997	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—sarcoma	0.000151	0.000997	CcSEcCtD
Propranolol—ABCB1—seminal vesicle—sarcoma	0.00015	0.00979	CbGeAlD
Propranolol—CYP1A2—liver—sarcoma	0.000144	0.00941	CbGeAlD
Propranolol—ABCB1—hematopoietic system—sarcoma	0.000142	0.0093	CbGeAlD
Propranolol—Nausea—Doxorubicin—sarcoma	0.000142	0.00094	CcSEcCtD
Propranolol—CYP1A1—liver—sarcoma	0.000142	0.00928	CbGeAlD
Propranolol—CYP3A5—liver—sarcoma	0.000139	0.00907	CbGeAlD
Propranolol—CYP1A1—lymph node—sarcoma	0.000109	0.00711	CbGeAlD
Propranolol—CYP2D6—testis—sarcoma	0.000108	0.00709	CbGeAlD
Propranolol—ABCB1—uterus—sarcoma	0.000108	0.00703	CbGeAlD
Propranolol—CYP3A4—liver—sarcoma	0.000104	0.00681	CbGeAlD
Propranolol—CYP2D6—liver—sarcoma	0.000103	0.0067	CbGeAlD
Propranolol—ABCB1—lymphoid tissue—sarcoma	0.0001	0.00655	CbGeAlD
Propranolol—ABCB1—bone marrow—sarcoma	9.13e-05	0.00596	CbGeAlD
Propranolol—ABCB1—testis—sarcoma	7.8e-05	0.0051	CbGeAlD
Propranolol—ABCB1—liver—sarcoma	7.38e-05	0.00482	CbGeAlD
Propranolol—ABCB1—lymph node—sarcoma	5.66e-05	0.0037	CbGeAlD
